No red flags in insider behavior — sales are small and offset by grants and exercises. Monitor next earnings report for fundamentals; this activity does not suggest material non-public information.
Price Chart
Executive Summary
PTC Therapeutics CEO Matthew Klein sold $170,600 of stock in an open-market transaction, while Director Stephanie Okey exercised options and sold 1,167 shares for $81,700. The CEO also received a non-cash award of 12,500 shares. Total open-market sales in the cluster amount to $252,300, representing a minor 0.005% of the company's $5.2B market cap.
Key Financial Metrics
Key Facts
- CEO Matthew Klein sold 2,662 shares for $170,581 in an open-market transaction.
- CEO also received a non-cash grant of 12,500 shares (no economic cost).
- Director Stephanie Okey exercised options and sold 1,167 shares for $81,690.
- All transactions are within normal insider activity patterns; no large-scale selling or coordinated exits.
- Total open-market sales: $252,271 (0.005% of $5.2B market cap).
Financial Impact
$252,271 in total open-market sales; non-cash transactions account for $0 in economic outflow.
Risk Factors
- Perception risk if media highlights CEO sale without context of concurrent share award.
- Option exercises followed by sales may signal profit-taking, but not unusual for directors.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (5 trades, 7d window) | cluster-PTCT-1773436832176 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 21, 2026 6w ago | Insider Cluster | $69.82 $65.26 | ▼ −6.53% | ▼ −6.00% | $63.46 (−9.11%) |
Jul 16, 2026 11w ago | Press Release | $78.52 $71.97 | ▲ +8.34% | ▲ +11.96% | $63.46 (+19.18%) |
Jul 16, 2026 11w ago | Insider Cluster | $78.52 $71.97 | ▼ −8.34% | ▼ −11.96% | $63.46 (−19.18%) |
Jul 13, 2026 11w ago | Insider Cluster | $81.33 $74.63 | ▼ −8.24% | ▼ −11.42% | $63.46 (−21.97%) |
Jul 8, 2026 12w ago | Insider Cluster | $88.57 $69.21 | ▼ −21.86% | ▼ −25.13% | $63.46 (−28.35%) |
Jun 26, 2026 13w ago | Insider Cluster | $81.57 $76.82 | ▼ −5.82% | ▼ −5.54% | $63.46 (−22.20%) |
Jun 16, 2026 15w ago | 8-K | $73.27 $78.06 | ▲ +6.54% | ▲ +6.34% | $63.46 (−13.39%) |
Jun 9, 2026 16w ago | 8-K | $73.35 $89.55 | ▲ +22.09% | ▲ +18.46% | $63.46 (−13.48%) |
May 19, 2026 19w ago | Insider Cluster | $71.02 $78.98 | ▲ +11.21% | ▲ +10.47% | $63.46 (−10.64%) |
May 15, 2026 19w ago | Insider Cluster | $70.15 $73.27 | ▲ +4.45% | ▲ +2.87% | $63.46 (−9.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access